ESR1 and neoplasm: ER- breast tumors, particularly those also lacking HER (human epidermal growth factor receptor) expression, are particularly deadly because unlike ER+ or HER+ breast cancers, targeted therapies have not yet been developed that can effectively reduce or eliminate tumor cells that have disseminated throughout the patient.